NGNE (Neurogene) Construction In Progress: $0.56 Mil (As of Mar. 2026)


NGNE Neurogene Inc NGNE
12 GF Score
Price $32.05
! 4 Warning Signs
View Full Analysis

What is Neurogene Construction In Progress?

Neurogene NGNE +5.26% 12 Construction In Progress is $0.56 Mil as of Mar. 2026. GuruFocus rates NGNE with a GF Score™ of 12/100. The stock has 4 warning signs investors should review.

Neurogene's quarterly construction in progress increased from Sep. 2025 ($0.17 Mil) to Dec. 2025 ($0.32 Mil) and increased from Dec. 2025 ($0.32 Mil) to Mar. 2026 ($0.56 Mil).

Neurogene's annual construction in progress increased from Dec. 2023 ($0.23 Mil) to Dec. 2024 ($1.31 Mil) but then declined from Dec. 2024 ($1.31 Mil) to Dec. 2025 ($0.32 Mil).

Neurogene Construction In Progress Historical Data

* Premium members only.

The historical data trend for Neurogene's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neurogene Construction In Progress Chart

Neurogene Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Construction In Progress
2.86 0.25 0.23 1.31 0.32

Neurogene Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 1.44 0.17 0.32 0.56
NGNE
12GF Score
Neurogene Inc NGNE
Construction In Progress is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neurogene Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

What does a Construction In Progress of $0.56 Mil mean?
Neurogene (NGNE) has a Construction In Progress of $0.56 Mil as of Mar. 2026. Construction in Progress records the amount of construction work that is not complete. View historical data on Neurogene and its competitors.
Is Neurogene's Construction In Progress too high?
Neurogene's current Construction In Progress is $0.56 Mil. Overall, Neurogene has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Neurogene's Construction In Progress compare to SGMT and IPSC?
Neurogene's Construction In Progress of $0.56 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Construction In Progress for a Biotechnology company?
A good Construction In Progress depends on the Biotechnology industry context. However, Construction In Progress should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Construction In Progress mean?
A high Construction In Progress can signal that a stock is expensive relative to its fundamentals. Construction in Progress records the amount of construction work that is not complete. View historical data on Neurogene and its competitors. Neurogene's current Construction In Progress is $0.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neurogene stock overvalued right now?
Neurogene (NGNE) has a current Construction In Progress of $0.56 Mil. The current Construction In Progress is $0.56 Mil. Neurogene's overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Construction In Progress calculated?
Construction In Progress is calculated from a company's financial statements. For Neurogene (NGNE), the current Construction In Progress is $0.56 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Neurogene Business Description

Other Exchanges UU8:Germany
Address 535 W 24th Street, 5th Floor, New York, NY, USA, 10011
Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACT(Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.
12GF Score

Get the complete analysis for NGNE

Construction In Progress is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$32.05
Price